| 书目名称 | Risk-Benefit Analysis in Drug Research | | 副标题 | Proceedings of an In | | 编辑 | J. F. Cavalla (Research Director) | | 视频video | | | 图书封面 |  | | 描述 | The appreciation of risk like the awareness of beauty lies very much in the eyes of the beholder. It involves a value judgement and can never be absolute. Yet paradoxically, modern society is demanding ever greater degrees of safety in the medicines it takes, to the extent that nothing short of the total absence of risk will be tolerated. Since 1960, and mainly as a result of the thalidomide tragedy, governmental regulation of testing and use of new medicines has grown apace throughout the world. It has derived impetus not only from the understandable wish of the public to seek protection, but also from the anxiety of bureaucrats and politicians not to be seen to have made mistakes. Both these concerns have been inflamed by the recognition of the media that all drugs make news and horror drugs make the best news of all. Prior to this time the physician and his cures enjoyed a relatively supportive public. It was true that quacks existed and were recognized as such but, in the main, people wanted to take medicines and expected them to do them good. | | 出版日期 | Conference proceedings 1981 | | 关键词 | drug; drug research; research | | 版次 | 1 | | doi | https://doi.org/10.1007/978-94-015-7132-6 | | isbn_softcover | 978-94-015-7134-0 | | isbn_ebook | 978-94-015-7132-6 | | copyright | MTP Press Limited 1981 |
The information of publication is updating
|
|
发表于 2025-3-21 19:28:25
